ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

FENC vs TECX // RSI-14 & 200D SMA MOMENTUM

Fennec Pharmaceuticals Inc. (NASDAQ) VS. Tectonic Therapeutic Inc. (NASDAQ) • 15-METRIC TALLY: FENC 3 — TECX 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: FENC
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FENC VS. TECX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC FENC TECX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -25.90% -35.00% +9.10 FENC /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -3.25% -15.04% +11.79 FENC /fcf-yield <GO>
Operating Margin -14.10% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -6.10% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.31 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 55.0 37.3 +17.70 FENC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $383.6M $400.8M -$17.1M TECX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR FENC REV TECX REV FENC GROSS % TECX GROSS % FENC FCF TECX FCF
FY 2025 $44.6M $0 — — -$12.5M -$60.3M
FY 2024 $47.5M $0 — — $27.0M -$59.2M
FY 2023 $21.3M $0 — — -$17.1M -$40.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FENC // BETA —
TECX // BETA —